We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current ATXI market cap is 2.6M. The company's latest EPS is USD -5.4283 and P/E is -0.25.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.07M | -2.12M | -3.71M | -2.82M | -3.16M |
| Net Income | 526k | 640k | -4.34M | -2.73M | -3.04M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -26.27M | -5.21M | -3.74M | -8.04M | -14.54M |
| Net Income | -25.91M | -5.15M | -3.73M | -3.55M | -10.38M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 502k | 1.85M | 3.31M | 4.99M | 2.63M |
| Total Liabilities | 5.02M | 1.2M | 1.41M | 1.16M | 973k |
| Total Equity | -4.52M | 654k | 1.9M | 3.83M | 1.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 8.92M | 3.25M | 3.96M | 6.85M | 1.85M |
| Total Liabilities | 2.12M | 886k | 509k | 3.58M | 1.2M |
| Total Equity | 6.8M | 2.36M | 3.45M | 3.27M | 654k |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.13M | -9.45M | -3.12M | -5.37M | -8.26M |
| Investing | -3M | -3M | N/A | N/A | N/A |
| Financing | 3.58M | 7.53M | 4.53M | 8.51M | 9.08M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.26M | -4.61M | -3.75M | -7.6M | -9.45M |
| Investing | N/A | -1M | N/A | N/A | -3M |
| Financing | 32.33M | N/A | 4.38M | 10.54M | 7.53M |
| Market Cap | 2.6M |
| Price to Earnings Ratio | -0.25 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.46 |
| Price to Book Ratio | 3.98 |
| Dividend Yield | - |
| Shares Outstanding | 1.91M |
| Average Volume (1 week) | 112.13k |
| Average Volume (1 Month) | 1.28M |
| 52 Week Change | -87.41% |
| 52 Week High | 15.00 |
| 52 Week Low | 1.22 |
| Spread (Intraday) | 0.1 (6.94%) |
| Company Name | Avenue Therapeutics Inc |
| Address |
3500 s dupont hwy dover, delaware 19901 |
| Website | https://www.avenuetx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
